rat bone marrow mesenchymal stem cells bmscs (Procell Inc)
Structured Review

Rat Bone Marrow Mesenchymal Stem Cells Bmscs, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+bone+marrow+mesenchymal+stem+cells+bmscs/pmc12686661-77-0-23?v=Procell+Inc
Average 86 stars, based on 1 article reviews
Images
1) Product Images from "Magnesium ion implantation enhances the osseointegration and vascularization of 3D-Printed CoCrMo alloy scaffolds for load-bearing orthopedic applications"
Article Title: Magnesium ion implantation enhances the osseointegration and vascularization of 3D-Printed CoCrMo alloy scaffolds for load-bearing orthopedic applications
Journal: Bioactive Materials
doi: 10.1016/j.bioactmat.2025.11.012
Figure Legend Snippet: Evaluation of biocompatibility, adhesion and migration ability of both BMSCs and HUVECs on CoCrMo-Mg scaffold. (A) Biocompatibility of BMSCs: (a) CCK-8 assay; (b) Live/dead staining of BMSCs at day 3; (c) Quantitative statistics of cell proliferation. (B) Biocompatibility of HUVECs: (a) CCK-8 assay; (b) Live/dead staining of HUVECs at day 3; (c) Quantitative statistics of cell proliferation. (C) Cell adhesion of BMSCs: (a) FE-SEM and EDS images of BMSCs co-cultured with CoCrMo and CoCrMo-Mg scaffolds for 48 h; (b) Quantitative statistics of cell length; (c) Quantitative statistics of filopodia per cell. (D) Cell adhesion of HUVECs: (a) FE-SEM and EDS images of HUVECs; (b) Quantitative statistics of cell length; (c) Quantitative statistics of filopodia per cell. (E) The process of Transwell assay in BMSCs and HUVECs cultured with CoCrMo and CoCrMo-Mg scaffolds. (F) Crystalline violet staining of migrated cells. (G) Migration counts of BMSCs and HUVECs. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.
Techniques Used: Migration, CCK-8 Assay, Staining, Cell Culture, Transwell Assay
Figure Legend Snippet: Evaluation of angiogenic, and osteogenic abilities in vitro . (A) Immunofluorescence staining of HUVECs for VEGF. (B) Fluorescence intensity quantification of VEGF. (C and D) The expression levels of angiogenesis-related genes VEGF and HIF-1α in HUVECs. (E) ELISA analysis of VEGF secretion by HUVECs. (F) Western blot analysis of angiogenesis-related proteins in HUVECs. (G and H) Quantitative analysis of Western blot in HUVECs normalized to β-actin. (I) Images of ALP staining on day 7 and 14. (J) Images of ARS staining on day 21 and 28. (K) Quantitative analysis of ALP detected by the ALP assay. (L) Quantitative analysis of calcium nodule elution. (M) Immunofluorescence staining of BMSCs for OPN. (N) Fluorescence intensity quantification of OPN. (O–Q) The expression levels of osteogenic-related genes OPN, COL-I and ALP in BMSCs. (R) Western blot analysis of osteogenesis-related proteins in BMSCs. (S–U) Quantitative analysis of Western blot in BMSCs normalized to β-actin. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.
Techniques Used: In Vitro, Immunofluorescence, Staining, Fluorescence, Expressing, Enzyme-linked Immunosorbent Assay, Western Blot, ALP Assay


